Hospital‐acquired venous thromboembolism (VTE) remains the number one safety issue in
hospitals and is estimated to cause more preventable deaths than the more publicized …

SUMMARY A national Venous Thromboembolism (VTE) Prevention Programme was
introduced in England in 2010, with limited subsequent study of its impact. Whilst the …

Introduction: Hospital-acquired venous thromboembolism (VTE) is a potentially fatal
complication of hospitalisation, with meta-analyses and guidelines supporting the use of …

Venous thromboembolism (VTE) remains a leading cause of preventable morbidity and
mortality associated with hospitalization. Despite evidence that providing appropriate …

Each year in Australia, about 1 in 1000 people develop a first episode of venous
thromboembolism (VTE), which approximates to about 20 000 cases. More than half of these …

VTE prophylaxis is effective and safe, but grossly underused in Australian hospitals n this
issue of the Journal, Ho and colleagues ( page 144) report their findings from a Perth …

The majority of hospitalised patients are at risk of venous thrombosis and one in ten hospital
deaths are due to pulmonary embolism. A report from the House of Commons Health …

Objective To explore the current practice of venous thromboembolism (VTE) prevention in
acute trusts. Design A qualitative research design was used to explore the perceived current …

Hospital-acquired venous thromboembolism (VTE) accounts for an estimated 25 000
preventable deaths per annum in the UK and is associated with significant healthcare costs …

Of an estimated 25 000 deaths in England each year attributable to hospital acquired
venous thromboemobolism (VTE), many are potentially preventable. 1 2 Despite the …